GPCR NewsJun 30, 20221 min readDr. Ross Bathgate becomes Scientific co-founder of LASEREDD TherapeuticsJuly 2022"I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics"Ross Bathgate Read more at the source #DrGPCR #GPCR #IndustryNews
July 2022"I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics"Ross Bathgate Read more at the source #DrGPCR #GPCR #IndustryNews
Emerging approaches for decoding neuropeptide transmissionNovember 2022 "Neuropeptides produce robust effects on behavior across species, and recent research has benefited from advances in...
Location bias contributes to functionally selective responses of biased CXCR3 agonistsNovember 2022 "Some G protein-coupled receptor (GPCR) ligands act as "biased agonists" that preferentially activate specific signaling...
Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...November 2022 Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell cycle and metastasis...
コメント